WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 33

Legislative bill overview

HB 33 would mandate that health insurance plans in Ohio cover prostate cancer screening tests without cost-sharing (copays, coinsurance, or deductibles). The bill applies to both state-regulated insurance plans and likely mirrors existing federal preventive care coverage requirements under the Affordable Care Act.

Why is this important

Prostate cancer is the second-leading cancer diagnosis among American men. Removing financial barriers to screening can improve early detection rates, particularly in underserved populations, though it also increases overall healthcare utilization and insurance costs that may be passed to consumers through premiums.

Potential points of contention

  • Clinical evidence debate: Major medical organizations (ACS, AUA) recommend shared decision-making rather than routine screening for average-risk men due to overdiagnosis concerns; mandating coverage may increase unnecessary screening
  • Cost allocation: Requiring insurers to cover screening without cost-sharing increases plan expenses, which could raise premiums for all policyholders or reduce coverage in other areas
  • Redundancy concerns: Federal law (ACA) already requires no-cost coverage of USPSTF-recommended preventive services; unclear if this bill adds new requirements or addresses implementation gaps in Ohio

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.